Abiopharma

Director Gilboa David Abraham 🟡 adjusted position in 1.7M shares (5 derivative) of Warby Parker Inc. (WRBY) at $25.55 Transaction Date: Sep 03, 2025 | Filing ID: 087903

Director Blumenthal Neil Harris 🟡 adjusted position in 4.2M shares (10 derivative) of Warby Parker Inc. (WRBY) at $25.55 Transaction Date: Sep 03, 2025 | Filing ID: 087899

Miller Steven Clive 🟡 adjusted position in 15.8K shares (4 derivative) of Warby Parker Inc. (WRBY) at $25.55 Transaction Date: Sep 03, 2025 | Filing ID: 087897

White Albert G III 🟢 acquired 10.0K shares of COOPER COMPANIES, INC. (COO) at $68.39 Transaction Date: Sep 05, 2025 | Filing ID: 006125

Graphjet Receives Nasdaq Letter

New Form DEFA14A - Silo Pharma, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085128 Size: 3 MB

New Form 144 - GoodRx Holdings, Inc. Filed: 2025-09-05 AccNo: 0001961863-25-000141 Size: 6 KB

New Form 144 - Axsome Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0001921094-25-001106 Size: 4 KB

New Form ARS - Silo Pharma, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085125 Size: 796 KB

New Form S-3/A - Vivos Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0001641172-25-026733 Size: 415 KB

Kooij Louise Frederika 🔴 sold 18.1K shares of NewAmsterdam Pharma Co N.V. (NAMS) at $25.09 Transaction Date: Sep 03, 2025 | Filing ID: 113276

New Form DEF 14A - Silo Pharma, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085119 Size: 4 MB

New Form 424B3 - Tivic Health Systems, Inc. Filed: 2025-09-05 AccNo: 0001683168-25-006729 Size: 222 KB

New Form 8-K - FIBROGEN INC Filed: 2025-09-05 AccNo: 0000921299-25-000007 Size: 525 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits

Le 24 septembre 2025, La Société de Gestion AGF Limitée annoncera ses résultats financiers pour le troisième trimestre de 2025